- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04836312
Intermittent Fasting Adherence and Self Tracking (iFAST)
A Soft Commitment Device to Encourage Intermittent Fasting in Patients With the Metabolic Syndrome
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
1.1. Non-Pharmacologic Interventions to Improve Blood Pressure Control: Despite the wide availability of multiple classes of antihypertensive agents, compelling data that blood pressure (BP) lowering reduces mortality and cardiovascular events, and decades of public health campaigns, half of American adults with hypertension do not achieve adequate BP control. Randomized controlled trials of interventions to improve BP control in patients with hypertension have largely focused on home blood pressure monitoring, nurse- or pharmacist-lead education and medication titration, and/or financial incentives. Though many of these interventions improve short-term blood pressure control, they are cost-additive to health systems, post-intervention data is mixed, and none have been widely implemented.
Though consensus guidelines recommend dietary changes to improve hypertension control, with a particular recommendation in favor of the DASH (Dietary Approaches to Stop Hypertension) diet, very few U.S. patients adhere to this complex dietary pattern. The DASH diet reduced systolic BP (SBP) by 11 mmHg in randomized controlled trials in which participants were provided with food, and 4 mmHg in a study testing a 6-month, 18-visit intensive lifestyle intervention intended to promote the DASH diet; however, BP control was not sustained 12 months after the end of the intensive intervention.
1.2. Effect of Intermittent Fasting on Metabolic Parameters: In contrast to the DASH diet, intermittent fasting (IF) is a dietary pattern that emphasizes temporal restriction of caloric intake rather than restricting the number of calories and/or changing the types of foods eaten. The simplest and most popular variation of IF involves restricting caloric intake to an 8-hour period each day, and consuming no calories for the other 16 hours (so-called 16:8 time-restricted feeding). In animal studies, IF has been shown to activate cellular pathways with potential disease-modifying benefits in a number of conditions. In small human studies, IF is associated with a reduction in SBP by 5-10 mmHg, LDL cholesterol by ~8 mg/dl, and weight by ~ 3 kg, though none of the studies of a time-restricted feeding regimen included concurrent controls. Some patients report that IF is easier to initiate and maintain than other dietary patterns, though this has not been tested empirically.
1.3. Commitment Devices to Promote Healthy Behaviors: Commitment devices are centered in theoretical research that posits a planner-doer framework, wherein an individual can be conceptualized as dual sub-selves: The planner, who cares about long-term well-being; and the doer, who cares only for the present and prioritizes immediate payoffs. Conflict between the motivations and priorities of the planner and the doer sub-selves results in failure to follow-through with a plan when the moment to act arrives. Commitment devices are mechanisms by which the planner sub-self constrains the actions of their future doer sub-self by making certain choices more costly. Hard commitments impose a financial penalty for failing to follow through on the commitment, and soft commitments impose a psychological penalty. Hard commitments have been shown to change health behaviors, as in a study where smokers forfeited money deposited in a savings account if they failed to quit smoking after 6 months. However, monetary losses may not be attractive to many people, and effective soft commitment devices may be more appealing.
Pre-clinical research suggests that both intra- and interpersonal commitments might be useful components of a soft commitment device. Intrapersonal commitments have also been framed as implementation intentions, or specific plans as to where, how, and/or when an action will be taken. In small experiments, smokers who set a quit date were more likely to quit, and college students who set a date and time to visit a vaccination clinic were more likely to receive their vaccination. Interpersonal commitments leverage social networks, so that the penalty involves letting down a support partner. Involvement of social networks has been used to increase physical activity and improve control of weight and blood glucose in patients with obesity and diabetes. Social networks have been used explicitly within the context of commitment devices to encourage deposits in a savings account in a study of Chilean micro-entrepreneurs who either attended or did not attend a weekly peer support group meeting. Weight loss studies encouraging participants to exercise and change their eating behavior have employed commitment devices, including some that leveraged the involvement of family members or friends of the participant, with mixed results.
1.4 Rationale for the IFAST Study: The IF dietary pattern, though not inspired by behavioral economic concepts, is structured to take advantage of them and thus may be particularly amenable to a robust commitment device intervention. Changing one's eating patterns to a complex new diet is a cognitively intense process that requires active consideration of complex information multiple times per day, leading to cognitive overload and impaired decision-making. By contrast, IF, especially time-restricted feeding, is cognitively very simple. This simplicity may help participants avoid cognitive overload, initiate the dietary pattern and adhere over the long term.
This study seeks to test how a robust soft commitment device, incorporating both intra- and interpersonal commitments, affects uptake and adherence to an intermittent fasting dietary pattern, as compared with control, in patients with obesity and hypertension
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Pennsylvania
-
Philadelphia, Pennsylvania, United States, 19104
- University of Pennsylvania
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Age 18 or older
- Body mass index > 30 kg/m2
- Systolic blood pressure > 150 mmHg
- Owns a smartphone or tablet operating the iOS or Android operating system
Exclusion Criteria:
- Unable or unwilling to provide informed consent, including but not limited to cognitive or language barriers (reading or comprehension)
- Type 1 diabetes
- Use of insulin or insulin secretagogues (sulfonylureas, metaglinides)
- Use of medications that require food intake
- Ongoing use of pharmacologic therapy for weight loss
- Self-reported eating disorder
- Other medical condition that could be harmed by intermittent fasting as judged by study physician
- Anticipated life expectancy less than 6 months
- Any other reason why it is not feasible to complete the entire 6-month study
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Health Services Research
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
No Intervention: Attention Control
Patients will be instructed via text message and email to fast at least 16 hours per day every day.
For the next 18 weeks, they will receive a daily text message via the Way to Health platform asking if they fasted for at least 16 hours over the past 24 hours.
If they fail to respond, reminder text messages will be sent.
Once per week, they will receive a text message asking them to weigh themselves and check their blood pressure, and reply with the results via text message
|
|
Experimental: Soft Commitment Device
Patients randomized to the commitment device arm will be asked to visit the Way to Health platform.
There, they will identify a support person, a family or friend who they speak to frequently and who is invested in their health.
They will then complete a series of questions intended to create implementation intentions.
Specifically, they will pick a time for their fast to begin each 24-hour period and a time for their fast to end.
They will also develop strategies to deal with hunger arising during a fast period.
After this process, they will sign a contract pledging to adhere to the 16:8 time-restricted feeding dietary pattern, and acknowledging that their support person will receive a copy of the contract and weekly updates about their adherence to the regimen.
|
Patients randomized to the commitment device arm will be asked to visit the Way to Health platform.
There, they will identify a support person, a family or friend who they speak to frequently and who is invested in their health.
They will then complete a series of questions intended to create implementation intentions.
Specifically, they will pick a time for their fast to begin each 24-hour period and a time for their fast to end.
They will also develop strategies to deal with hunger arising during a fast period.
After this process, they will sign a contract pledging to adhere to the 16:8 time-restricted feeding dietary pattern, and acknowledging that their support person will receive a copy of the contract and weekly updates about their adherence to the regimen.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Adherence to the Intermittent Fasting Regimen, Captured Via Daily Text Message, Over 18 Weeks, Expressed in Days Per Week
Time Frame: Weeks 1-18
|
Adherence to the IF regimen, captured via daily text message, over 18 weeks, expressed in days per week.
This will measure adherence to the IF regimen throughout the 12 week intervention period and the 6 week follow-up period.
|
Weeks 1-18
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Adherence to the IF Regimen, Captured Via Daily Text Message, Over 12 Weeks, Expressed in Days Per Week
Time Frame: Weeks 1-12
|
Adherence to the IF regimen, captured via daily text message, over 12 weeks, expressed in days per week.
This will measure adherence to the IF regimen for the 12 week intervention period only.
|
Weeks 1-12
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Exploratory analyses will compare change in blood pressure in patients that were adherent to IF ≥ 4 days per week vs. < 4 days per week
Time Frame: Weeks 1-18
|
Exploratory analyses will compare change in blood pressure in patients that were adherent to IF ≥ 4 days per week vs. < 4 days per week.
This will be captured using wrist-worn blood pressure cuffs.
The values will be reported via text messages.
|
Weeks 1-18
|
Exploratory analyses will compare change in weight in patients that were adherent to IF ≥ 4 days per week vs. < 4 days per week
Time Frame: Weeks 1-18
|
Exploratory analyses will compare change in weight in patients that were adherent to IF ≥ 4 days per week vs. < 4 days per week.
This will be captured using digital scales.
The values will be reported via text messages.
|
Weeks 1-18
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Alexander Fanaroff, MD, MHS, University of Pennsylvania
- Principal Investigator: Mitesh Patel, MD, MBA, MS, University of Pennsylvania
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Estimated)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 844153
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Hypertension
-
National Taiwan University Hospital Hsin-Chu BranchRecruitingHypertension,Essential | Hypertension, MaskedTaiwan
-
University of Alabama at BirminghamTroy UniversityCompletedHypertension | Hypertension, Resistant to Conventional Therapy | Uncontrolled Hypertension | Hypertension, White CoatUnited States
-
BayerCompletedPrimary HypertensionChina
-
Columbia UniversityAgency for Healthcare Research and Quality (AHRQ)Active, not recruitingWhite Coat Hypertension | Hypertension,EssentialUnited States
-
Addpharma Inc.Completed
-
Universidade Federal de Santa MariaCompletedHealthy Volunteers | Hypertension, EssentialBrazil
-
Sheffield Teaching Hospitals NHS Foundation TrustUniversity of SheffieldCompletedIdiopathic Pulmonary Arterial Hypertension | Chronic Thromboembolic Pulmonary HypertensionUnited Kingdom
-
China Academy of Chinese Medical SciencesGuang'anmen Hospital of China Academy of Chinese Medical SciencesCompletedHypertension, Resistant to Conventional Therapy | Primary HypertensionChina
-
Sulaiman AlRajhi CollegesUnknownHypertension, Essential | β-hydroxybutyrate
Clinical Trials on Soft Commitment Device
-
Zimmer BiometEnrolling by invitationSLAP Lesion | Capsular Shift/Capsulolabral Reconstruction | Deltoid Repair | Bankart Lesions | Biceps Tendon Disorder | Acromioclavicular; Dislocation | Rotator Cuff Tear RepairSpain, United States
-
Hannah AntonyNot yet recruiting
-
Fu Jen Catholic UniversityNot yet recruitingChronic Pulmonary DiseaseTaiwan
-
Ullevaal University HospitalNorwegian Fund for Postgraduate Training in PhysiotherapyCompleted
-
Milton S. Hershey Medical CenterNot yet recruitingSafety Issues | Device Dislodgement | Device Intolerance | Device Ineffective
-
University Hospital HeidelbergCompleted
-
Anne Roche, MACompletedQuality of Life | AgingUnited States
-
Francisco Garcia TorresUniversidad de CórdobaRecruiting
-
National Bureau of Economic Research, Inc.Northwestern UniversitySuspendedSmoking Cessation | Weight LossUnited States
-
Boston University Charles River CampusAmerican Heart Association; Harvard University; Spaulding Rehabilitation HospitalCompleted